PMC:7600245 / 56294-56488
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T246 | 125-133 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T570 | 16-26 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T571 | 28-29 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T56250 | 43-54 | Chemical | denotes | leflunomide | http://purl.obolibrary.org/obo/CHEBI_6402 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T422 | 0-194 | Sentence | denotes | Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1725 | 106-114 | Species | denotes | patients | Tax:9606 |
1734 | 43-54 | Chemical | denotes | leflunomide | MESH:D000077339 |
1737 | 125-133 | Disease | denotes | COVID-19 | MESH:C000657245 |